Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioInvent International AB

+ Add to Watchlist

BINV:SS

2.3300 SEK 0.0500 2.19%

As of 11:29:59 ET on 03/31/2015.

Snapshot for BioInvent International AB (BINV)

Open: 2.3100 Day's Range: 2.2800 - 2.3600 Volume: 56,028
Previous Close: 2.2800 52wk Range: 1.9000 - 3.3500 1-Yr Rtn: -20.48%

Stock Chart for BINV

No chart data available.
  • BINV:SS 2.3300
  • 1D
  • 1M
  • 1Y
2.2800
Interactive BINV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BINV

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. OMX -
Earnings Per Share (SEK) (ttm) -0.5200
Est. EPS (SEK) (12/2015) -0.1930
Est. PEG Ratio -
Market Cap (M SEK) 262.80
Shares Outstanding (M) 112.79
30 Day Average Volume 356,071
Price/Book (mrq) 5.0126
Price/Sale (ttm) 4.8256
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BINV

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BINV

BioInvent International AB is a research and development company within biotechnology. The Company has created human antibody libraries that can be used in a broad range of applications. BioInvent delivers proteins to drug and biotechnology companies, grants licenses for use of its libraries, and establishes partnerships to develop and manufacture protein based drugs.

Michael S OredssonPresident/CEOPer-Anders JohanssonSenior VP:Tech Operations
Martin WilesSenior VP:Business DevelopmentBjoern FrendeusVP:Preclinical Research
More Company Profile & Key Executives for BINV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil